← Adam Feuerstein ✡️Trade on Robinhood →Trade on Robinhood →
“$REPL RP1 will be reviewed in "late July," per the company this morning.”
@adamfeuerstein
FDA AdCom for REPL's RP1 oncolytic therapy confirmed for late July, just days ahead of an August 2 approval decision for advanced melanoma.
REPLLONG@ $11.62
$11.35-2.34%
since call Jun 26
peak +6.1%
“$CAPR deramiocel will be reviewed on July 29, per a notice in the Federal Register.”
@adamfeuerstein
FDA AdCom for CAPR's deramiocel confirmed for July 29, a binary binary catalyst ahead of Aug 22 PDUFA date for DMD cell therapy.
CAPRLONG@ $27.06
$3.89-85.61%
since call Jun 26
TIMESTAMPS
in post
in post